Citius Pharma(CTXR) - 2024 Q2 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR For the transition period from ______________ to ______________ Citius Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) incorporation or organization) Identification No.) 11 Commerce Drive, First Floor, Cranford, NJ 07016 (Address of principal executive of ices) (Zip Code) Securities registered pu ...